AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 221 filers reported holding AMICUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,159,463 | +15.8% | 917,719 | +19.6% | 0.00% | 0.0% |
| Q2 2023 | $9,634,500 | -6.9% | 767,078 | -17.8% | 0.00% | 0.0% |
| Q1 2023 | $10,343,965 | +3.2% | 932,729 | +13.6% | 0.00% | 0.0% |
| Q4 2022 | $10,025,619 | +32.3% | 821,099 | +13.1% | 0.00% | +50.0% |
| Q3 2022 | $7,579,000 | +342.4% | 725,944 | +355.1% | 0.00% | +100.0% |
| Q2 2022 | $1,713,000 | +18.9% | 159,527 | +4.9% | 0.00% | – |
| Q1 2022 | $1,441,000 | -21.4% | 152,132 | -4.2% | 0.00% | – |
| Q4 2021 | $1,833,000 | +13.2% | 158,719 | -6.4% | 0.00% | – |
| Q3 2021 | $1,619,000 | +12.7% | 169,533 | +13.7% | 0.00% | – |
| Q2 2021 | $1,437,000 | +26.8% | 149,094 | +30.0% | 0.00% | – |
| Q1 2021 | $1,133,000 | -97.3% | 114,662 | -93.7% | 0.00% | -100.0% |
| Q4 2020 | $41,927,000 | +61.4% | 1,815,829 | -1.3% | 0.01% | +33.3% |
| Q3 2020 | $25,982,000 | +28.2% | 1,840,088 | +36.9% | 0.01% | +28.6% |
| Q2 2020 | $20,273,000 | +75.5% | 1,344,381 | +7.5% | 0.01% | +40.0% |
| Q1 2020 | $11,551,000 | -81.7% | 1,250,093 | -80.7% | 0.01% | -75.0% |
| Q4 2019 | $63,101,000 | +32.1% | 6,478,544 | +8.7% | 0.02% | +66.7% |
| Q3 2019 | $47,778,000 | -36.2% | 5,957,377 | -0.7% | 0.01% | -36.8% |
| Q2 2019 | $74,853,000 | +12.6% | 5,997,843 | +22.7% | 0.02% | -13.6% |
| Q1 2019 | $66,461,000 | +30.1% | 4,886,821 | -8.4% | 0.02% | +10.0% |
| Q4 2018 | $51,099,000 | -24.8% | 5,334,031 | -5.1% | 0.02% | -4.8% |
| Q3 2018 | $67,922,000 | -0.3% | 5,618,022 | +28.7% | 0.02% | -8.7% |
| Q2 2018 | $68,160,000 | +43.3% | 4,363,645 | +38.0% | 0.02% | +27.8% |
| Q1 2018 | $47,559,000 | +709.8% | 3,162,187 | +674.8% | 0.02% | +800.0% |
| Q4 2017 | $5,873,000 | +558.4% | 408,119 | +590.1% | 0.00% | – |
| Q3 2017 | $892,000 | +53.5% | 59,142 | +2.5% | 0.00% | – |
| Q2 2017 | $581,000 | +43.8% | 57,693 | +1.8% | 0.00% | – |
| Q1 2017 | $404,000 | -94.4% | 56,647 | -94.2% | 0.00% | -100.0% |
| Q3 2016 | $7,270,000 | -21.7% | 982,382 | -10.6% | 0.00% | -50.0% |
| Q1 2016 | $9,289,000 | +23.9% | 1,099,329 | +42.3% | 0.00% | +33.3% |
| Q4 2015 | $7,495,000 | -27.0% | 772,661 | +5.3% | 0.00% | -25.0% |
| Q3 2015 | $10,268,000 | +171033.3% | 733,936 | +187607.4% | 0.00% | – |
| Q2 2015 | $6,000 | – | 391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |